Opportunistic infections caused by fungi are common in human immunodeficien
cy virus (HIV)-infected patients. We focused on severe infections as indica
ted by detectable fungemia. Medical charts available for patients having po
sitive blood cultures with fungi at the University of Geneva Hospital were
retrospectively (1989 to 2000) reviewed. Of 328 patients with fungemia duri
ng the study period, 315 (96%) medical charts were accessible. Of these 315
patients, 37 (12.2%) were HIV-positive, and 13 (35.1%) died within 6 month
s from their episode of fungemia. This was a lower mortality rate than for
the HIV seronegative patients (45.8%). The median and average age of the 34
HIV-positive patients was 37.2 years, and 24 (64.9%) were males. Cryptococ
cus neoformans (n=14) and Candida albicans (n=12) were the most frequently
identified species, followed by Candida glabrata (n=3), of which 3 were mix
ed C. albicans + C. glabrata, Histoplasma capsulatum (n=2), and Penicillium
marneffei (n=2). The frequency decreased significantly (p<0.007) from the
time period 1993 to 1996 (n=21) to the period 1997 to 2000 (n=6). Fungemias
in HIV-infected patients have declined significantly since 1996. This coin
cides with the introduction of highly active antiretroviral therapy (HAART)
.